| |
WoundTEK
Announces Expanded Distribution Channel for Its
S.T.A.R.(TM) Suture Tension Adjustment
Reel,
A Leader in Soft Tissue Repair.
Newport, RI, Sept. 23, 2005
/ PRNewswire-FirstCall/ -- WoundTEK,
Inc. Today announced that the Company has expanded the distribution
channel for their Suture Tension Adjustment Reel, better known as
the S.T.A.R. Device, into the South East United States through Specialty
Surgical Instrumentation, Inc (SSI). The expanded territory will
allow the company’s wound closure/soft tissue repair product
to be sold throughout North Carolina, South Carolina, Georgia, Florida,
Tennessee, Alabama, and Mississippi. The expanded distribution includes
hundreds of hospitals that SSI has been selling to since the early
seventies. “SSI is one of the largest and most respected medical
device distributors in the United States, We are delighted to have
them representing us in the South East territory. This expansion
will surely impact our bottom line,” said Andrew Reilly, President
of WoundTEK.
The S.T.A.R. device is the first minimally invasive
tissue expansion device; it is one of the most effective methods
for closure of large open wounds caused by trauma or surgery. Its
ability to bring large skin deficits to a linear closure rapidly
has won the device much acclaim since its introduction and it is
rapidly becoming the leading device for most delayed primary closures.
SSI is a leading medical device distributor based
in Nashville, TN. Established in 1976 by Louis Wallace and Charles
Mann. “We are extremely optimistic about the opportunity to
represent WoundTEK and to sell the S.T.A.R. device. We believe that
this product will become a leading device in a very short time frame.”
Said Lou Wallace, President of SSI.
The S.T.A.R. is a class one FDA accepted device
and is available through WoundTEK distributors throughout the United
States.
The potential target markets for the S.T.A.R.
device, according to industry sources, accounts for over 2,200,000
procedures annually in the U.S. with a total potential market in
excess of $650 million. Open fractures, decubitus ulcers, burns,
and severe trauma, represent the largest areas of opportunity.
About WoundTEK Corporation. WoundTEK is a leading
developer and manufacturer of wound closure products with applications
in the cardiology, orthopaedics, thoracic, plastic and reconstructive,
trauma, and general surgical and wound care markets.
# # #
Cautionary Note for Forward-Looking Statements.
This press release contains forward-looking statements that reflect
the Company's current expectations about its prospects and opportunities.
The Company tried to identify these forward-looking statements by
using words such as "expects," "anticipates,"
"estimates," "plans," "will," "forecasts,"
or similar expressions, but these words are not the exclusive means
for identifying such statements. The Company cautions that a number
of risks, uncertainties, and other important factors could cause
the Company's actual results to differ materially from those in
the forward-looking statements including, without limitation, demand
for and the Company's ability to develop and manufacture biomaterial
products, additional regulatory approvals, and competition from
other technologies in the marketplace. For a more detailed discussion
of these and other factors, please see the Company's SEC filings.
Except as expressly required by the federal securities laws, the
Company undertakes no obligation to update or revise any forward-looking
statements, whether as a result of new information, changed circumstances
or future events or for any other reason.
SOURCE WoundTEK Inc. -0- 09/23/2005 /CONTACT:
Marketing Dept. +1-866-249-STAR/
/Web site: http://www.woundtekinc.com CO: WoundTEK, Inc . 8 Fair
Street – Suite 8, Newport, Rhode Island 02840 IN: JS -- PHF005
-- 3626 09/23/2005 07:00 EDT http://www.prnewswire.com
|
|
